Shuttle Pharmaceuticals Holdings (SHPH) Other Working Capital Changes (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Other Working Capital Changes of -$904.0 for Q1 2026, down 332.54% year-over-year from $388.76 in Q1 2025, and little changed quarter-over-quarter from -$904.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$904.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 332.54% year-over-year to -$904.0; the TTM figure through Mar 2026 stood at -$3154.0 (down 710.8% YoY), while the FY2025 annual figure was -$2459.0, down 959.79% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$904.0, roughly flat from -$904.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $9388.0 in Q3 2023, with the low at -$1894.0 in Q1 2023.
- The 3-year median for Other Working Capital Changes is $156017.0 (2025), against an average of $455774.7.
- Peak annual rise in Other Working Capital Changes reached 671.78% in 2026, while the deepest fall reached 671.78% in 2026.
- Shuttle Pharmaceuticals Holdings' Other Working Capital Changes stood at -$1707.0 in 2022, then surged by 489.16% to $6643.0 in 2023, then tumbled by 103.19% to -$212.0 in 2024, then tumbled by 326.42% to -$904.0 in 2025, then changed by 0.0% to -$904.0 in 2026.
- Business Quant data shows SHPH's Other Working Capital Changes at -$904.0 in Q1 2026, -$904.0 in Q4 2025, and -$905.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -904.00 |
| Mar 31, 2026 | -904.00 |
| Mar 31, 2026 | -904.00 |
| Dec 31, 2025 | -904.00 |
| Dec 31, 2025 | -904.00 |
| Dec 31, 2025 | -904.00 |
| Sep 30, 2025 | -905.00 |
| Sep 30, 2025 | -905.00 |
| Sep 30, 2025 | -905.00 |
| Jun 30, 2025 | -441.00 |
| Jun 30, 2025 | -441.00 |
| Jun 30, 2025 | -441.00 |
| Mar 31, 2025 | -209.00 |
| Mar 31, 2025 | -209.00 |
| Mar 31, 2025 | -209.00 |
| Dec 31, 2024 | -212.00 |
| Dec 31, 2024 | -212.00 |
| Dec 31, 2024 | -212.00 |
| Sep 30, 2024 | -205.00 |
| Sep 30, 2024 | -205.00 |